- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Top 5 AJMC® Articles of October 2018
Here are the top 5 articles for the month of October.
Hi, I’m Jaime Rosenberg for The American Journal of Managed Care®. Here are the top 5 articles for the month of October.
Number 5: A study assessing adherence to National Comprehensive Cancer Network guidelines in the neoadjuvant treatment of breast cancer concluded that adherence to the guidelines leads to improved outcomes.
Number 4: A phase 3 trial has found that some patients with hard-to-treat leukemia and lymphoma showed significant improvement and longer progression-free survival with duvelisib
Number 3: Drs James P Allison and Tasuku Honjo were awarded the 2018 Nobel Prize in Physiology or Medicine for their research showing the potential of immune checkpoint inhibitors in cancer.
Number 2: During a session at the National Association of ACOs Fall 2018 conference, panelists discussed how accountable care organizations can design and implement new strategies that deliver high-quality, low-cost care for patients with complex, chronic conditions.
Number 1: A new law signed by California Governor Jerry Brown will put new requirements on pharmacy benefit managers in the state, including barring so-called gag clauses that prevented pharmacists from telling consumers when they would save money by paying cash for a prescription instead of getting it through insurance.
To read all of these articles and more, visit AJMC.com
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More
Pegcetacoplan for PNH More Cost-Effective Than Anti-C5 Monoclonal Antibodies
April 18th 2024A cost-utility analysis conducted from the perspective of the Italian health system found that pegcetacoplan was more effective and less costly than 2 complement 5 (C5) inhibitors for the treatment of paroxysmal nocturnal hemoglobinuria (PNH).
Read More
